The primary investment objective of the scheme is to seek to generate continuous returns by investing in equity and equity related or fixed-income securities of Pharma and other associated companies.
Disclaimer: This is neither
an offer nor a solicitation to purchase or sell securities. The
information and views contained on this site are believed to be reliable,
but no responsibility (or liability) is accepted for errors of fact or
opinion. Writers and contributors may be trading in, or have positions in
the securities mentioned in their articles. Neither ValueNotes nor any of
the contributors accepts any liability arising out of use of the above
information/article. Reproduction in whole or in part without written
permission is prohibited.